•  



Antiatherosclerotic Effect of L- thyroxine and Verapamil Combination on Thoracic Aorta of Hyperlipidemic Rabbits
بان جمعة قاسم
Authors : Muayyad Sraibit Abbod, Faruk H. Al-Jawad, Adnan A. Anoze, Mufeda Ali Jawad, Ban J.Qasim
Atherosclerosis which results from gradual deposition of lipids in medium and large arteries is a leading cause of mortality worldwide. This study was done to determine the effect of L- thyroxine with verapamil combination on the development of atherosclerosis in thoracic aorta of hyperlipidemic induced rabbits. Twenty four healthy rabbits were randomly divided into three equal groups: first group was given standard diet, second group fed with high cholesterol diet (%2 cholesterol) and third group was given high cholesterol diet (2% cholesterol) and treated by L-thyroxine combined with verapamil for eight weeks. The lipid profile and heart rate were measured for all groups. At the end of study, Histopathological examination of thoracic aorta was done in all groups. The high cholesterol diet cause highly significant difference in total serum cholesterol (TC), LDL, VLDL, TG levels and body weight in addition to atherosclerotic changes of thoracic aorta. The using of L-thyroxine combined with Verapamil induced highly significant reduction in TC, LDL, VLDL, TG levels and body weight while histopathological examination showed decrease atherosclerotic changes in thoracic aorta. This indicates that combination of L-thyroxin with verapamil can effectively prevent the progress of atherosclerosis without the cardiac side effect of L-thyroxine (tackycardia). This is likely due to antihyperlipidemic, and antioxidant effects of this combination. Keywords: Atherosclerosis, L-thyroxine, verapamil, hyperlipidemia, lipid profile.

(FULL ARTICLE LINK) Read more ...
30-06-2014